Contents:

1. Introduction 1.1 Statement of Report 1.2 About This Report 1.3 Scope of the Report 1.4 Objectives 1.5 Methodology 1.6 Executive Summary 2. Disposable Syringe Markets 2.1 Overview 2.2 Infection Control and Safety 2.3 Hospital Consolidations Pressure Companies to Reduce Prices 2.4 Needleless Injector Manufacturers Forge Strategic Alliances 2.5 Technological Advancements in Disposable Syringes 3. Syringe Market Segments 3.1 Overview 3.1.1 World Market 3.1.2 U.S. Market 3.2 Total Reusable Needle and Syringe Market 3.3 Total Disposable Needle and Syringe Market 3.3.1 Drivers of Safety Syringes 3.3.2 Restraints to Safety Syringes 3.4 Pre-filled Syringes 3.5 Insulin Injector Pens 3.6 Needleless Injectors 3.7 Vaccination Injectors 3.8 Needle and Syringe Market Trends 3.8.1 Market Segments 3.8.2 Customer Needs 3.8.3 Competitor Analysis 3.8.4 Target Markets for Specialty Syringes 3.8.5 Third Party Reimbursement 3.8.6 Regulation 3.8.7 Drug Discovery Trends 3.8.8 Demographic Shifts 3.8.9 Managed Care Initiatives 3.8.10 Growth in Home Healthcare 4. Technology Development and Sterilization Methods 4.1 Disposable Syringes 4.1.1 Autodestruct Syringes 4.1.2 SoloShot™ 4.2 Monodose Syringes 4.3 Pre-filled Syringes 4.3.1 Features of Pre-filled Membrane Syringes 4.3.1.1 Products in Pre-filled Syringes 4.3.1.2 Compatibility of Drug Components 4.3.1.3 Lyophilized Drugs and Powders 4.3.1.4 Dual-chambered Syringes 4.3.1.5 Pre-filled Diluent Syringes 4.3.1.6 Needle Safety Devices for Pre-filled Syringes 4.3.1.7 Sterility Maintenance 4.3.2 Pen Syringes 4.3.2.1 Technical Advances in Pens 4.3.2.2 Advantages of Pens 4.3.2.3 Pen Types and Styles 4.3.2.4 Pre-filled Pens 4.3.2.5 Reusable Pens 4.3.2.6 Device Preparation 4.3.2.7 Autopen 4.3.2.8 Unifine Pentips 4.3.3 Autoject 4.4 Insulin Syringes 4.5 Jet Injectors 4.6 Insulin Pens 4.7 Uniject™ Injection Device 4.8 Microneedle 4.9 Needle Free Injection 4.9.1 Hypospray 4.10 Glass Pre-fillable Syringes 4.11 Retractable Syringe 4.12 Ultrasafe Passive Delivery Systems 4.13 Ultrasmall Syringes and Microsyringes 4.14 Tip Lok® Syringes 4.15 Product Profiles 4.15.1 Gettig Guard™ 4.15.2 Inviro SNAP! ® 4.15.3 Maxxon Safety Syringe 4.15.4 Monoject Magellan™ 4.15.5 Needle-Pro 4.15.6 Point Lok® 4.15.7 SafetyGlide™ 4.16 SC Injection Technology 5. Business Trends 5.1 Market Drivers 5.2 Market Prospects 5.3 Marketing and Distribution 5.4 Competitive Landscape 5.5 Business Developments 5.6 Acquisitions and Partnerships 5.7 Key Players 5.7.1 Kendall 5.7.2 Becton Dickinson 5.7.3 C.R. Bard 5.7.4 International Medication Systems 5.7.5 Terumo Medical Corporation 6. Future Technologies 6.1 Thermostable Vaccines and Vaccine Vial Monitors 6.2 Sugar Glass 6.3 Issues in Technology Transfer for AD Syringes 7. Regulatory Measures 7.1 Safety Syringes in Europe 7.2 Safety Syringe Regulations and Recommendations 7.3 Reimbursement Outlook for Injectables 8. Corporate Profiles 9. Corporate Directory Appendix 1: FDA Approved Syringe Manufacturers Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick Safety Device List Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing Appendix 4: Frequently Asked Questions for the Needlestick and Safety Prevention Act INDEX OF FIGURES Figure 3.1: U.S. Safety Needle and Syringe Market Figure 6.1: Strategy of the "Sugar Project" INDEX OF TABLES Table 2.1: Global Market for Needles and Syringes, 2001-2010 Table 3.1: Global Market for Injection Devices by Category Table 3.2: Worldwide Dollar Market for Needles and Syringes, 1996-2010 Table 3.3: Worldwide Unit Market for Needles and Syringes, 1996-2010 Table 3.4: U.S. Dollar Market for Needles and Syringes, 1999-2010 Table 3.5: Worldwide Disposable Needle and Syringe Market, 1998 2006 Table 3.6: Worldwide Market for Disposable Needles and Syringes by Region Table 3.7: Worldwide Safety Syringe Unit Sales, 1998 2006 Table 3.8: Worldwide Safety Syringe Dollar Volume, 1998 2006 Table 3.9: Share of Worldwide Safety Syringes Market by Competitor Table 3.10: Share of Worldwide Market for Safety Syringes by Region Table 3.11: Worldwide Pre-filled Syringe Unit Sales, 1998 2010 Table 3.12: Worldwide Pre-filled Syringe Dollar Volume, 1998 2006 Table 3.13: Share of Worldwide Pre-filled Syringe Market by Competitor Table 3.14: Share of Worldwide Market for Pre-filled Syringes by Region Table 3.15: Worldwide Insulin Injector Pen Dollar Volume, 1998 2006 Table 3.16: Worldwide Market for Needle Free Injectable Drug Delivery Systems, 1996-2005 Table 3.17: Worldwide Needleless Injector Dollar Volume, 1998 2006 Table 3.18: Worldwide Vaccination Injector Unit Sales, 1998 2006 Table 3.19: Share of Worldwide Market for Vaccination Injectors by Region Table 3.20: Worldwide Vaccination Injector Dollar Volume, 1998 2006 Table 3.21: Share of Worldwide Vaccination Injector Market by Competitor Table 3.22: Summary of Strengths and Weaknesses of Available Syringes Table 3.23: Annual Change Per Capita in Healthcare Spending and Gross Domestic Product, 1994 2004 Table 4.1: Injection Data Using Soloshot and Disposable Syringes Table 4.2: Summary Data for Doses by Soloshot and Disposable Syringes Table 4.3: Wastage Analysis (Per Vial Used) Table 4.4: Important Injectable Drug Therapies Using Pre-filled Devices Table 4.5: Region-wise Market of Pre-filled Syringes Table 4.6: Worldwide Pre-filled Syringe Unit Sales, 1998 2006 Table 4.7: Worldwide Pre-filled Syringe Dollar Volume, 1998 2004 Table 4.8: Insulin Delivery Systems Percent Retail Market Share Table 4.9: Insulin Delivery Systems Percent Retail Market Share by Company Table 4.10: Commonly-Available Insulin Syringes Table 4.11: Features of Available Insulin Pumps Table 4.12: Features of Available Jet Injectors Table 4.13: Currently Available Insulin Delivery Pens Table 4.14: Summary of Clinical and Field Experience with the Uniject Device

Companies Mentioned

Some of the companies mentioned include: - Kendall - Becton Dickinson - C.R. Bard - International Medication Systems - Terumo Medical Corporation